SCHEMBL25877949

SCHEMBL25877949

Cc1cc(C=O)c(C)c(OCc2ccccc2)c1OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.45
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
ERN1 O75460 2/20 0.41
HPGD P15428 2/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CDK4 P11802 1/20 0.41
CCNB1 P14635 1/20 0.41
CCND1 P24385 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25877526 0.91 PTPN1 (0.48) PTPN1MAOAMAOBTDP1L3MBTL1
SCHEMBL25877421 0.85 MAOA (0.42) PTPN1MAOAMAOBTDP1L3MBTL1
SCHEMBL25817126 0.85 PTPN1 (0.45) PTPN1MAOAMAOBTDP1L3MBTL1
SCHEMBL24140500 0.84 ERN1 (0.50) TDP1L3MBTL1MAPTMAPK1LMNA
SCHEMBL22067805 0.84 ERN1 (0.50) PTPN1MAOAMAOBTDP1L3MBTL1
SCHEMBL20607402 0.82 POLB (0.43) PTPN1MAOAMAOBLMNAPOLB
SCHEMBL25877765 0.81 PTPN1 (0.51) PTPN1MAOAMAOBTDP1L3MBTL1
SCHEMBL25877366 0.81 ERN1 (0.50) PTPN1TDP1L3MBTL1MAPTMAPK1
SCHEMBL25877759 0.81 PTPN1 (0.45) PTPN1MAOAMAOBTDP1L3MBTL1
SCHEMBL25877469 0.81 PTPN1 (0.45) PTPN1MAOAMAOBTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234943-A1 TREX1 INHIBITORS AND USES THEREOF TEMPEST THERAPEUTICS, INC. 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234943-A1 TREX1 INHIBITORS AND USES THEREOF FEN1, ERCC4, DCLRE1B PTPN1 1749/4885MAOA 2749/4885MAOB 2815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.